Severe Sepsis Completed Phase 1 Trials for Nivolumab (DB09035)

Also known as: Sepsis, Severe

IndicationStatusPhase
DBCOND0031268 (Severe Sepsis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02960854A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock.Other